Dissecting the role of CD4+ T cells autoimmune diabetes through the use of TCR transgenic mice

Immunological Reviews

Volumn 169, Issue , 1999, Pages 55-65

  Suri, Anish ^a   Katz, Jonathan D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNE DISEASE; CELL DEATH; CELL TYPE; DISEASE COURSE; DISEASE PREDISPOSITION; HELPER CELL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; GENES, MHC CLASS II; HUMANS; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL;

EID: 0032768476     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1999.tb01306.x     Document Type: Review

References (79)

1. 1. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 1994;15:516-542.
2. 2. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996;85:291-297.
3. 3. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992;51:285-322.
4. + T cell subsets are required for transfer of diabetes in nonobese diabetic mice. J Immunol 1988;140:52-58.
5. 5. O'Reilly LA, et al. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur J Immunol 1991;21:1171-1180.
6. 6. Kurrer MO, Pakala SV, Hanson HL, Katz JD. β Cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 1997;94:213-218.
7. 7. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997;46:750-757.
8. 8. O'Brien BA, Harmon BV, Cameron DP, Allan DJ. β-Cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 1996;178:176-181.
9. 9. Todd JA. Genetics of type I diabetes. Pathol Biol 1997;45:219-227.
10. 10. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995;13:179-200.
11. 11. Grewal IS, Flavell RA. New insights into insulin dependent diabetes mellitus from studies with transgenic mouse models. Lab Invest 1997;76:3-10.
12. 12. Katz JD, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993;74:1089-1100.
13. + islet-specific T cell clone. Science 1990;249:1433-1436.
14. 14. Haskins K, Portas M, Bradley B, Wedmann D, Lafferty KJ. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 1988;37:1444-1448.
15. 15. Scaglia L, Smith FE, Bonner-Weir S. Apoptosis contributes to the involution of β cell mass in the post partum rat pancreas. Endocrinology 1995;136:5461-5468.
16. 16. Cunningham JM, Green IC. Cytokines, nitric oxide and insulin secreting cells. Growth Regul 1994;4:173-180.
17. 17. Cope AP. Regulation of autoimmunity by proinflammatory cytokines. Curr Opin Immunol 1998;10:669-676.
18. 18. Chervonsky AV, et al. The role of Fas in autoimmune diabetes. Cell 1997;89:17-24.
19. 19. Itoh N, et al. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 1997;186:613-618.
20. 20. Matiba B, Mariani SM, Krammer PH. The CD95 system and the death of a lymphocyte. Semin Immunol 1997;9:59-68.
21. 21. Ohashi PS, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65:305-317.
22. 22. Kagi D, Odermatt B, Seiler P, Zinkernagel RM, Mak TW, Hengarter H. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med 1997;186:989-997.
23. 23. Kagi D, Odermatt B, Ohashi PS, Zinkernagel RM, Hengartner H. Development of insulitis without diabetes in transgenic mice lacking perforin dependent cytotoxicity. J Exp Med 1996;183:2143-2152.
24. 23a. Pakala SV, Chivetta M, Kelly CB, Katz JD. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α. J Exp Med 1999;189:1053-1062.
25. 24. Shultz LD, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995;154:180-191.
26. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993;42:44-55.
27. + T cells in the intiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996;26:1762-1769.
28. 27. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 1996;183:67-76.
29. 28. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-793.
30. 29. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995;268:1185-1188.
31. + Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 1995;95:2979-2985.
32. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995;16:34-38.
33. 32. Trembleau S, Germann T, Gately MK, Adorini L. The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 1995;16:383-386.
34. 33. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995;181:817-821.
35. 34. Mueller R, Krahl T, Sarvetnick N. Pancreatic expression of interleukin 4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 1996;184:1093-1099.
36. 35. Sarvetnick N, et al. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 1990;346:844-847.
37. 36. Campbell IL, Kay TW, Oxbrow L, Harrison LC. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 1991;87:739-742.
38. 37. Rapoport MJ, et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993;178:87-99.
39. 38. Shimada A, Charlton B, Rohane P, Taylor-Edwards C, Fathman CG. Immune regulation in type 1 diabetes. J Autoimmun 1996;9:263-269.
40. 39. Tian J, et al. Nasal administration of glutamate, decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996;183:1561-1567.
41. 40. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation? Diabetes 1994;43:613-621.
42. 41. Cameron MJ, et al. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J Immunol 1997;159:4686-4692.
43. 42. Wang B, Gonzalez A, Hoglund P, Katz JD, Benoist C, Mathis D. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 1998;47:1207-1211.
44. 43. Wogensen L, Lee MS, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune mediated destruction of β cells in nonobese diabetic mice. J Exp Med 1994;179:1379-1384.
45. 44. Pakala SV, Kurrer MO, Katz JD. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med 1997;186:299-306.
46. 45. Lafaille JJ, et al. Myelin basic protein-specific T helper 2 (Th2) Cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from disease. J Exp Med 1997;186:307-312.
47. 46. King C, et al. TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 1998;8:601-613.
48. 47. Dardenne M, Lepault F, Bendelac A, Bach JF. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur J Immunol 1989;19:889-895.
49. 48. Mason D, Powrie F. Control of immune pathology by regulatory T cells. Curr Opin Immunol 1998;10:649-655.
50. 49. Boitard C, Yasunami R, Dardenne M, Bach JF. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989;169:1669-1680.
51. + subset that inhibits this autoimmune potential. J Exp Med 1993;177:627-636.
52. 51. Saoudi A, Seddon B, Heath V, Fowell D, Mason D. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol Rev 1996;149:195-216.
53. +CD8 thymocytes that express L-selectin protect rats from diabetes upon adoptive transfer. Eur J Immunol 1996;26:2702-2708.
54. + suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J Autoimmun 1996;9:331-339.
55. + (NKT) thymocytes prevent insulin-depedent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998;187:1047-1056.
56. 281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998;188;1831-1839.
57. + T cells. Curr Opin Immunol 1995;7:367-374.
58. + like thymocytes in the NOD mouse. Eur J Immunol 1996;26:2989-2998.
59. 58. Gombert JM, et al. Early defect of immunoregulatory T cells in autoimmune diabetes. CR Acad Sci III 1996;319:125-129.
60. +CDR CD8 thymocytes. J Autoimmun 1997;10:279-285.
61. + T cells. J Exp Med 1996;183:2669-2674.
62. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
63. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998;160:1212-1218.
64. 63. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases J Immunol 1995;155:1151-1164.
65. + naturally anergic and suppresive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
66. - immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
67. 66. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
68. + T cells in recovery from antigen-induced autoimmune disease. J Exp Med 1993;178:909-916.
69. 68. Kumar V, Stellrecht K, Sercarz E. Inactivation of T cell receptor peptide specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE). J Exp Med 1996;184:1609-1617.
70. 69. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987;329:599-604.
71. 70. Acha-Orbea H, McDevitt HO. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc Natl Acad Sci USA 1987;84:2435-2439.
72. 71. Lund T, et al. Prevention of insulin-dependent diabetes mellitus in non obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 1990;345:727-729.
73. 72. Miyazaki T, et al. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 1990;345:722-724.
74. 73. Quartey Papafio R, et al. Aspartate at position 57 of nonobese diabetic I-Ag7 β-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. J Immunol 1995;154:5567-5575.
75. g7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 1996;156:450-458.
76. g7 dependent reaction. Proc Natl Acad Sci USA 1998;95:1721-1724.
77. 76. Schmidt D, Verdaguer J, Averill N, Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 1997;186:1059-1075.
78. 77. Luhder F, Katz J, Benoist C, Mathis D. Major histocompatibility complex class II molecules can protect from diabetes by positive selecting T cells with additional specificies. J Exp Med 1998;187:379-387.
79. g7 class II MHC-chain mutant. J Immunol 1998;161:4489-4492.